GlassScriptPhysician profile
Jordan Womack
NPI 1205221017
$407.89
in general payments reported to CMS, 2019-2025
12 companies · $50.58 in 2025
The $50.58 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.16 · 2020: $14.07 · 2021: $51.62 · 2022: $92.75 · 2023: $128 · 2025: $50.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vaporox, INC. | $83.03 | 2023 | Vht-200 Wound Treatment System |
| Smith+Nephew, INC. | $81.58 | 2019-2022 | |
| Stryker Corporation | $39.97 | 2019 | |
| Treace Medical Concepts, INC. | $28.22 | 2025 | |
| Integra Lifesciences Corporation | $27.44 | 2021 | |
| Grt US Holding, INC. | $26.93 | 2022 | |
| Abbvie INC. | $26.45 | 2023 | Qulipta |
| Anika Therapeutics, INC. | $24.18 | 2021 | |
| Depuy Synthes Sales INC. | $22.36 | 2025 | Va-Lcp |
| Paratek Pharmaceuticals, INC. | $18.23 | 2023 | Nuzyra |
| Zyla Life Sciences, INC. | $15.41 | 2019 | |
| Tactile Systems Technology INC | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Womack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.